Plus Therapeutics Inc (PSTV)
1.18
-0.02
(-1.67%)
USD |
NASDAQ |
Nov 22, 16:00
1.20
+0.02
(+1.69%)
After-Hours: 20:00
Plus Therapeutics Free Cash Flow: -11.95M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
September 30, 2024 | -11.95M |
June 30, 2024 | -10.66M |
March 31, 2024 | -11.67M |
December 31, 2023 | -13.01M |
September 30, 2023 | -13.33M |
June 30, 2023 | -15.18M |
March 31, 2023 | -15.17M |
December 31, 2022 | -13.73M |
September 30, 2022 | -14.12M |
June 30, 2022 | -12.17M |
March 31, 2022 | -11.79M |
December 31, 2021 | -10.42M |
September 30, 2021 | -11.07M |
June 30, 2021 | -11.08M |
March 31, 2021 | -10.50M |
December 31, 2020 | -8.927M |
September 30, 2020 | -4.67M |
June 30, 2020 | -4.881M |
March 31, 2020 | -4.21M |
December 31, 2019 | -5.973M |
September 30, 2019 | -9.443M |
June 30, 2019 | -9.616M |
March 31, 2019 | -11.21M |
December 31, 2018 | -12.11M |
September 30, 2018 | -13.86M |
Date | Value |
---|---|
June 30, 2018 | -15.39M |
March 31, 2018 | -17.81M |
December 31, 2017 | -19.62M |
September 30, 2017 | -19.49M |
June 30, 2017 | -19.91M |
March 31, 2017 | -20.46M |
December 31, 2016 | -19.60M |
September 30, 2016 | -20.07M |
June 30, 2016 | -21.63M |
March 31, 2016 | -21.00M |
December 31, 2015 | -21.09M |
September 30, 2015 | -21.43M |
June 30, 2015 | -22.79M |
March 31, 2015 | -27.16M |
December 31, 2014 | -31.35M |
September 30, 2014 | -35.90M |
June 30, 2014 | -36.50M |
March 31, 2014 | -35.11M |
December 31, 2013 | -35.08M |
September 30, 2013 | -34.04M |
June 30, 2013 | -34.00M |
March 31, 2013 | -35.03M |
December 31, 2012 | -33.40M |
September 30, 2012 | -32.96M |
June 30, 2012 | -32.76M |
Free Cash Flow Range, Past 5 Years
-15.18M
Minimum
Jun 2023
-4.21M
Maximum
Mar 2020
-10.73M
Average
-11.38M
Median
Free Cash Flow Benchmarks
Perspective Therapeutics Inc | -40.58M |
Retractable Technologies Inc | -9.854M |
InfuSystems Holdings Inc | 2.464M |
Xtant Medical Holdings Inc | -17.28M |
Catheter Precision Inc | -8.381M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -3.68M |
Cash from Investing (Quarterly) | -0.009M |
Free Cash Flow Per Share (Quarterly) | -0.4702 |
Free Cash Flow Yield | -147.7% |